Reuters
@Reuters·4.2M subscribers·86.9K videos
Eli Lilly says its drug cuts COVID risk in nursing homes
Posted
January 21, 2021
Views
785
Likes
15
Engagement
1.91%
January 21, 2021
785
15
1.91%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
1:03Now PlayingDrugmaker Eli Lilly said a trial of its antibody drug, bamlanivimab, showed it can reduce the risk of COVID-19 by 80% for nursing home residents.
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on
Follow Reuters on Facebook
Follow Reuters on Twitter
Follow Reuters on Instagram
#COVID19 #News
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
